BioGaia AB (publ) (BIOG-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) has a cash flow conversion efficiency ratio of 0.046x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr50.77 Million ≈ $5.46 Million USD) by net assets (Skr1.10 Billion ≈ $118.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BioGaia AB (publ) market capitalisation for the company's overall valuation and market capitalisation.
BioGaia AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how BioGaia AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
BioGaia AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioGaia AB (publ) ranked by their cash flow conversion efficiency. Explore BIOG-B cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Trinity Capital Inc
NASDAQ:TRIN
|
0.027x |
|
Shenzhen Clou Electronics Co Ltd
SHE:002121
|
0.146x |
|
Implenia AG
SW:IMPN
|
0.364x |
|
First Mid Illinois Bancshares Inc
NASDAQ:FMBH
|
0.039x |
|
Aryzta AG
SW:ARYN
|
0.302x |
|
Myers Industries Inc
NYSE:MYE
|
0.109x |
|
Donnelley Financial Solutions Inc
NYSE:DFIN
|
0.193x |
|
EVEREST MED.LTD DL-0001
F:6HN
|
N/A |
Annual Cash Flow Conversion Efficiency for BioGaia AB (publ) (2002–2025)
The table below shows the annual cash flow conversion efficiency of BioGaia AB (publ) from 2002 to 2025. View BioGaia AB (publ) share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.31 Billion ≈ $141.43 Million |
Skr306.57 Million ≈ $32.99 Million |
0.233x | +7.75% |
| 2024-12-31 | Skr1.72 Billion ≈ $185.52 Million |
Skr373.22 Million ≈ $40.16 Million |
0.216x | +3.14% |
| 2023-12-31 | Skr2.03 Billion ≈ $218.39 Million |
Skr425.96 Million ≈ $45.84 Million |
0.210x | +29.81% |
| 2022-12-31 | Skr1.97 Billion ≈ $212.26 Million |
Skr318.94 Million ≈ $34.32 Million |
0.162x | +36.82% |
| 2021-12-31 | Skr1.88 Billion ≈ $202.03 Million |
Skr221.88 Million ≈ $23.88 Million |
0.118x | -6.72% |
| 2020-12-31 | Skr1.75 Billion ≈ $187.92 Million |
Skr221.26 Million ≈ $23.81 Million |
0.127x | -56.48% |
| 2019-12-31 | Skr507.87 Million ≈ $54.66 Million |
Skr147.85 Million ≈ $15.91 Million |
0.291x | -19.22% |
| 2018-12-31 | Skr508.12 Million ≈ $54.68 Million |
Skr183.12 Million ≈ $19.71 Million |
0.360x | -24.90% |
| 2017-12-31 | Skr463.89 Million ≈ $49.92 Million |
Skr222.62 Million ≈ $23.96 Million |
0.480x | +34.69% |
| 2016-12-31 | Skr415.18 Million ≈ $44.68 Million |
Skr147.93 Million ≈ $15.92 Million |
0.356x | +20.03% |
| 2015-12-31 | Skr395.83 Million ≈ $42.60 Million |
Skr117.50 Million ≈ $12.64 Million |
0.297x | -17.76% |
| 2014-12-31 | Skr344.59 Million ≈ $37.08 Million |
Skr124.38 Million ≈ $13.39 Million |
0.361x | +45.81% |
| 2013-12-31 | Skr316.86 Million ≈ $34.10 Million |
Skr78.44 Million ≈ $8.44 Million |
0.248x | -66.30% |
| 2012-12-31 | Skr456.79 Million ≈ $49.16 Million |
Skr335.56 Million ≈ $36.11 Million |
0.735x | +132.47% |
| 2011-12-31 | Skr230.35 Million ≈ $24.79 Million |
Skr72.79 Million ≈ $7.83 Million |
0.316x | -14.17% |
| 2010-12-31 | Skr187.32 Million ≈ $20.16 Million |
Skr68.97 Million ≈ $7.42 Million |
0.368x | +11.31% |
| 2009-12-31 | Skr161.12 Million ≈ $17.34 Million |
Skr53.29 Million ≈ $5.73 Million |
0.331x | +128.07% |
| 2008-12-31 | Skr132.42 Million ≈ $14.25 Million |
Skr19.20 Million ≈ $2.07 Million |
0.145x | +170.52% |
| 2007-12-31 | Skr94.91 Million ≈ $10.21 Million |
Skr5.09 Million ≈ $547.55K |
0.054x | +580.80% |
| 2006-12-31 | Skr74.53 Million ≈ $8.02 Million |
Skr-831.00K ≈ $-89.43K |
-0.011x | +91.97% |
| 2005-12-31 | Skr71.78 Million ≈ $7.72 Million |
Skr-9.97 Million ≈ $-1.07 Million |
-0.139x | -155.28% |
| 2004-12-31 | Skr91.50 Million ≈ $9.85 Million |
Skr22.99 Million ≈ $2.47 Million |
0.251x | +27.74% |
| 2003-12-31 | Skr114.85 Million ≈ $12.36 Million |
Skr22.59 Million ≈ $2.43 Million |
0.197x | -14.88% |
| 2002-12-31 | Skr127.99 Million ≈ $13.77 Million |
Skr29.57 Million ≈ $3.18 Million |
0.231x | -- |
About BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more